MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans.

Autor: Luukkonen PK; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Internal Medicine, Yale University, New Haven, Connecticut, USA. Electronic address: panu.luukkonen@fimnet.fi., Juuti A; Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Sammalkorpi H; Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Penttilä AK; Department of Gastrointestinal Surgery, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Orešič M; Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland; School of Medical Sciences, Örebro University, Örebro, Sweden., Hyötyläinen T; Department of Chemistry, Örebro University, Örebro, Sweden., Arola J; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Orho-Melander M; Department of Clinical Sciences in Malmö, Lund University Diabetes Center, Lund University, Malmö, Sweden., Yki-Järvinen H; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Jazyk: angličtina
Zdroj: Journal of hepatology [J Hepatol] 2020 Sep; Vol. 73 (3), pp. 725-726. Date of Electronic Publication: 2020 May 26.
DOI: 10.1016/j.jhep.2020.04.021
Abstrakt: Competing Interests: Conflict of interest The authors declare no conflicts of interest that pertain to this manuscript. Please refer to the accompanying ICMJE disclosure forms for further details.
Databáze: MEDLINE